Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia

Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia

ABSTRACT: Objective: To report the effectiveness of cinacalcet in treating tertiary hyperparathyroidism (THPT) associated with chronic treatment of hypophosphatemia in a patient with fibroblast growth factor-23 (FGF-23)-mediated tumor-induced osteomalacia (TIO).Methods: We review the clinical course...

Full description

Bibliographic Details
Main Authors: Sophia Hu, MD, Seena C. Aisner, MD, Sara E. Lubitz, MD
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520303370

Internet

http://www.sciencedirect.com/science/article/pii/S2376060520303370

Similar Items